Loading…

Browse All Grants

606,025 grants found

Filters
Reset

Showing 25,62125,640 of 606,025 grants

Active NON-SBIR/STTR RPGS
Therapeutic Value of BNC-1 in Addressing Tau Pathology in TBI
NATIONAL INSTITUTE ON AGING University of Kentucky United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Each year, approximately 200,000 Americans aged 65 and older seek medical care for traumatic brain injuries (TBI), primarily from closed head injuries (CHI...

$4.24M
USD
Active NON-SBIR/STTR RPGS
Helping Patients, Families, and Clinicians Make Shared Decisions about Therapies for Dementia
NATIONAL INSTITUTE ON AGING University of Colorado Denver United States 2024 – 2026

PROJECT SUMMARY On July 6th, 2023, the FDA approved Lecanemab-IRMB, the first drug with evidence of slowing the rate of cognitive decline through a reduction in amyloid plaques, th...

$2.34M
USD
Active NON-SBIR/STTR RPGS
Development of an amphiphilic PET probe to detect CD206+ microglia/macrophages in Alzheimer's disease
NATIONAL INSTITUTE ON AGING Massachusetts General Hospital United States 2024 – 2026

Activated macrophages and microglia are key players in the innate response in the pathogenesis of Alzheimer’s disease (AD). They are closely associated with b-amyloid deposits in b...

$4.55M
USD
Active OTHER RESEARCH-RELATED
The Impact of Social-Contextual Stressors on Psychopharmacological Mechanisms of Smoking Cessation and Relapse among Socioeconomically Disadvantaged Young Adults who Smoke Cigarettes
NATIONAL INSTITUTE ON DRUG ABUSE Brown University United States 2024 – 2026

PROJECT SUMMARY Socioeconomically disadvantaged young adults (SDYA) are at a disproportionately greater risk of tobacco- related illness and disease compared to non-disadvantaged y...

$1.41M
USD
Active NON-SBIR/STTR RPGS
Feasibility study for assessing processes and outcomes related to gender affirming care
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD... University of Colorado Denver United States 2024 – 2026

PROJECT SUMMARY In the United States (U.S.) an estimated 300,000 youth, ages 13-17-years, identify as transgender and, over the past decade, increasing numbers of youth have sought...

$4.29M
USD
Active NON-SBIR/STTR RPGS
Intermingling of circulating B cells and cerebral spinal fluid B cells with advancing age
NATIONAL INSTITUTE ON AGING Western Michigan University School of Me... United States 2024 – 2026

The broad, long term objective of this project is to elucidate the role that the B cell arm of the immune system plays in the pathophysiology of aging from the stand-point of, and...

$4.18M
USD
Active NON-SBIR/STTR RPGS
Molecular pharmacology of xylazine at adrenoceptors: Relation to necrotic skin lesions associated with chronic intravenous administration
NATIONAL INSTITUTE ON DRUG ABUSE Mercer University Macon United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT The α2-adrenergic receptor (α2R) agonist xylazine has been used in veterinary medicine for decades owing to its anesthetic, muscle relaxant, and analgesic...

$3.88M
USD
Active OTHER RESEARCH-RELATED
Research Advising and Mentoring Professionals for Underrepresented Peoples (RAMP UP)
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES University of Alaska Fairbanks United States 2024 – 2029

Project Summary The biomedical workforce fails to represent the diverse makeup of the US population. Numerous groups, including Indigenous and those from rural backgrounds, are sig...

$5.18M
USD
Active NON-SBIR/STTR RPGS
The mechanisms of cerebral microcirculation response to transcranial stimulation.
NATIONAL INSTITUTE ON AGING Lovelace Biomedical Research Institute United States 2024 – 2026

Transcranial alternating current stimulation (tACS) is a relatively new non-invasive electrical stimulation technique (tES) where a sinusoidal oscillating low-voltage electric curr...

$5.97M
USD
Active NON-SBIR/STTR RPGS
Negative allosteric modulation of mu opioid receptors to reverse fentanyl overdose
NATIONAL INSTITUTE ON DRUG ABUSE Trustees of Indiana University United States 2024 – 2026

Abstract Fentanyl’s high potency, facile synthesis, abuse liability, and propensity to cause profound respiratory depression via the mu opioid receptor (MOR) have combined to creat...

$2.38M
USD
Active NON-SBIR/STTR RPGS
Novel methods for estimating adult mortality using a survey
NATIONAL INSTITUTE ON AGING University of California Berkeley United States 2024 – 2026

ABSTRACT Accurate estimates of adult death rates are critical to good science and health policy. In most high-income countries, adult death rates are directly calculated since civi...

$4.13M
USD
Active NON-SBIR/STTR RPGS
Using a Pragmatic Randomized Rollout Trial to Evaluate Implementation Strategies to Promote Smoking Treatment and Cancer Prevention for Salvation Army Clients
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2024 – 2026

ABSTRACT / PROJECT SUMMARY The prevalence of combustible cigarette tobacco use remains high among socioeconomically disadvantaged Americans despite declines in the broader populati...

$6.4M
USD
Active NON-SBIR/STTR RPGS
Expand human umbilical cord blood hematopoietic stem cells with PPAR-a agonists
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Coriell Institute for Medical Research United States 2024 – 2026

Expand human umbilical cord blood hematopoietic stem cells with PPAR-a agonists Abstract Hematopoietic stem cells (HSCs) are defined by their self-renewal potential and ability to...

$1.47M
USD
Active OTHER RESEARCH-RELATED
Estimating the treatment effect of cardiovascular medications to modify the risk for future cognitive decline in older adults
NATIONAL INSTITUTE ON AGING Yale University United States 2024 – 2029

Project Summary/Abstract Candidate: I aspire to become an independent clinician-investigator working at the intersection of cardiovascular disease and aging, focused on the impact...

$2.43M
USD
Active NON-SBIR/STTR RPGS
Elucidate Gene-environmental interactions employed by Pb in promoting ADRD in aging brains
NATIONAL INSTITUTE ON AGING Purdue University United States 2024 – 2029

Project Summary Alzheimer's disease and related dementia (AD/ADRD) affect a large percentage of population in the US creating a signficant health care burnden to society. A fe...

$7.85M
USD
Active NON-SBIR/STTR RPGS
AD GxE: In vivo and in vitro modeling of gene x environment interactions
NATIONAL INSTITUTE ON AGING University of North Carolina Chapel Hill United States 2024 – 2029

Project Summary Common genetic variants identified through genome-wide association studies have been reproducibly associated with risk for Alzheimer’s disease (AD), but the functio...

$7.63M
USD
Active NON-SBIR/STTR RPGS
Examining the effect of cadmium metal exposure on Alzheimer's disease genetic alleles using herpes viral infected cerebral organoids
NATIONAL INSTITUTE ON AGING University of Massachusetts Med Sch Worc... United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Several genetic variants within immune system genes like APOE, TREM2, BIN1, CR1, etc have been associated with Alzheimer’s disease (AD). There is also evid...

$8.37M
USD
Active NON-SBIR/STTR RPGS
Aberrant protein S-nitrosylation mediates Gene-Environment Interactions in AD/ADRD
NATIONAL INSTITUTE ON AGING Scripps Research Institute, The United States 2024 – 2029

Project Summary Alzheimer’s disease (AD) and AD-related dementias (ADRD) represent the most common forms of neurodegenerative disease in patients above 65-years of age. Growing evi...

$9.14M
USD
Active NON-SBIR/STTR RPGS
Phase II trial of avutometinib plus defactinib in RAF dimer-driven thyroid cancers
FOOD AND DRUG ADMINISTRATION Sloan-Kettering Inst Can Research United States 2024 – 2028

ABSTRACT/SUMMARY Two rare types of thyroid cancer currently have extremely poor outcomes. Radioiodine-refractory (RAIR), recurrent and/or metastatic (R/M) differentiated thyroid ca...

$1.91M
USD
Active NON-SBIR/STTR RPGS
Gene Therapy for LCA5-Assocated Inherited Retinal Degeneration: Extension to Pediatric Cohorts
FOOD AND DRUG ADMINISTRATION University of Pennsylvania United States 2024 – 2028

PROJECT SUMMARY / ABSTRACT Advances in genetics and genomics have raised hopes for the development of gene-based treatments for inherited retinal diseases (IRDs) which are single-g...

$8.26M
USD